Search

A study conducted in Indonesia explored the relationship between the tcdA and tcdB genes of Clostridium difficile and diarrhea duration in elderly patients. The research found no significant relationship between the presence of these genes and diarrhea duration in the elderly patients studied. This study highlights the importance of understanding the genetic factors associated with Clostridium difficile infections in vulnerable populations. [Extracted from the article]

A recent study from Tabriz University of Medical Sciences explores the use of Clostridium novyi-NT spores to induce apoptosis in HPV-positive cervical cancer tumors in mice. The research found that the spores triggered apoptosis via the mitochondrial pathway, leading to tumor regression in a mouse model. This study highlights a potential treatment strategy for cervical cancer, particularly in hypoxic regions where traditional treatments may be less effective. [Extracted from the article]

Researchers from the University of Campinas in Brazil conducted a study on controlling Alicyclobacillus acidoterrestris spores on orange surfaces using antimicrobial photodynamic treatments (APDT). The study found that specific treatments with photosensitizers and light sources were effective in inhibiting the growth of A. acidoterrestris spores. The research suggests that implementing APDT technology could significantly improve the control of A. acidoterrestris in the fruit juice industry, potentially revolutionizing on-farm and pre-processing decontamination practices. The study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). [Extracted from the article]

A patent application titled "Clostridium Butyricum Compositions And Methods Of Using The Same" was published online, detailing a method for treating graft-versus-host disease (GVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation by administering Clostridium butyricum. The application highlights the potential benefits of using Clostridium butyricum to increase gut biodiversity and improve clinical outcomes in patients with autoimmune diseases, cancer, and non-cancer hematological disorders. The patent application aims to address the challenges associated with GVHD treatment and offers a novel approach using Clostridium butyricum as a live biotherapeutic product. [Extracted from the article]

The article discusses the secretion of a biofilm matrix protein from Clostridium perfringens, a Gram-positive anaerobic spore-forming bacterial pathogen. The study explores the role of type IV pili-associated genes in secreting this protein, which forms intermolecular isopeptide bonds, enhancing the physical strength of the biofilm. The research suggests that C. perfringens may use these genes to secrete the main biofilm protein BsaA, contributing to our understanding of bacterial secretion mechanisms. [Extracted from the article]

A recent study conducted at Rochester General Hospital explored the impact of frailty on Clostridium difficile (CDI) patients. The study, which analyzed data from 144,611 CDI patients, found that frail CDI patients had higher mortality rates and were more likely to experience complications such as septic shock and acute kidney injury. Frailty was also associated with increased resource utilization and elevated 30-day readmission rates. The research suggests that recognizing frailty as a determinant of CDI outcomes can help clinicians in risk stratification and guide tailored interventions for this population. [Extracted from the article]

The article discusses a study on enhancing acetic acid and alcohol production from CO2 through the heterologous expression of the carbon monoxide dehydrogenase gene from Clostridium sp. The study evaluates the performance of engineered strains in microbial electrochemical systems, showing improved metabolic performance and higher yields of formic acid, acetic acid, and ethanol compared to wild-type and negative control strains. The research highlights the effectiveness of genetic and process engineering, particularly codh overexpression and IPTG induction, in optimizing microbial electrosynthesis for biofuel and biochemical production from C1 gases. [Extracted from the article]

Researchers at Dartmouth College have focused on Clostridium thermocellum, a bacterium with potential for producing cellulosic biofuels. By engineering pyrophosphate-free glycolysis in this organism, they were able to increase ethanol production by 38%. This study demonstrates that optimizing the metabolic pathways through engineering can enhance product titers, although further improvements are needed for commercial applications. The research was funded by the Center For Bioenergy Innovation and published in Biotechnology for Biofuels and Bioproducts. [Extracted from the article]

Researchers at the Oswaldo Cruz Institute in Rio de Janeiro, Brazil, have identified potent Bacillus thuringiensis (Bt) strains effective against Aedes aegypti mosquito larvae, which transmit diseases like dengue, Zika, and chikungunya. The study evaluated 13 Bt strains, with strains 1644, 1608A, and 1656 showing high larvicidal activity. These findings suggest the potential of these Bt strains as biocontrol agents against Aedes aegypti larvae, offering a safe and sustainable method to reduce mosquito populations. The research was supported by various organizations, including the Oswaldo Cruz Foundation and the Brazilian Agricultural Research Corporation. [Extracted from the article]

A study conducted by Mie University Graduate School of Medicine in Japan explored the preventive effects of Clostridium butyricum MIYAIRI 588 (CBM) on pouchitis in children with ulcerative colitis. The research found that oral administration of CBM after ileostomy closure significantly reduced the incidence of acute pouchitis in pediatric patients who underwent radical surgery for ulcerative colitis. The study suggests that CBM may be effective in preventing postoperative pouchitis in children with ulcerative colitis. [Extracted from the article]

A recent study conducted at Nanjing Agricultural University in Jiangsu, People's Republic of China, focused on developing effective vaccines to prevent necrotic enteritis (NE) in broiler chickens. The research investigated the protective efficacy of vaccine formulations targeting Eimeria maxima and Clostridium perfringens, resulting in improved weight gains, higher survival rates, and reduced lesion scores in chickens following a dual-infection challenge model. The study concluded that these vaccine preparations show promise in controlling and preventing coccidiosis-induced NE in chickens. For more information, the research article can be found in Poultry Science, 104(2):104687. [Extracted from the article]

A study conducted in Nanjing, People's Republic of China, focused on developing a rapid visual detection method for Clostridium perfringens in chicken products. The method, called helical loop-mediated isothermal amplification (HAMP), showed high specificity and sensitivity in detecting the pathogen. This research, supported by various agricultural science and technology funds, highlighted the potential of HAMP for on-site detection of C. perfringens in chicken products, offering a rapid and accurate testing alternative to traditional methods. [Extracted from the article]

Researchers from Jiangsu, China, conducted a study on the relationship between gut microbiota (GM) and nonunion, a bone metabolic disorder. Using Mendelian Randomization analysis, they found that certain bacterial genera were associated with either a protective effect or a higher risk of nonunion. The study also identified immune cell types that were positively or negatively associated with nonunion, suggesting a potential mediation effect. This research provides valuable insights into the potential therapeutic strategies targeting the gut microbiome for nonunion treatment. [Extracted from the article]

Researchers at Henan Agricultural University in Zhengzhou, People's Republic of China, conducted a study on the impact of sodium diacetate on Clostridium perfringens spores. The research found that sodium diacetate hindered the transition of germinated spores into vegetative cells by damaging the inner membrane and compromising DNA integrity. This study provides guidance on using sodium diacetate to control the germination and outgrowth of spore-forming bacteria in food products. The research was peer-reviewed and published in the Journal of Food Safety. [Extracted from the article]

The patent issued by Vedanta Biosciences Inc. focuses on methods for decreasing dysbiosis and restoring a microbiome in individuals by administering purified bacterial strains. Dysbiosis, an imbalance in the gut microbiome, can lead to health issues, and the patent aims to address this through targeted treatments. The patent outlines specific bacterial strains and dosages for treating conditions like Clostridium difficile infection, emphasizing the importance of microbiome balance for overall health. [Extracted from the article]

A patent application titled "Compositions And Methods" by Seres Therapeutics Inc. aims to address the need for diverse microbiota in the gastrointestinal tract to treat diseases and disorders. The therapeutic compositions consist of bacterial populations with specific strains formulated for oral or gastric administration to prevent or treat gastrointestinal conditions. The patent application highlights the importance of microbiota in maintaining health and the potential benefits of altering dysbiosis through innovative treatment methods. [Extracted from the article]

Finch Therapeutics Holdings LLC has been issued a patent for compositions related to fecal microbiota transplantation, primarily used to treat Clostridium difficile infection. The patent focuses on lyophilized formulations of fecal microbiota preparations that can maintain cell viability for extended periods, offering potential treatments for various conditions like C. diff infection, autism spectrum disorder, and irritable bowel syndrome. This development addresses the logistical challenges of obtaining fresh FMT material, potentially improving access to this therapy. [Extracted from the article]

Researchers at Kunming Children's Hospital in China have conducted a study on Clostridium butyricum, a probiotic that shows potential in treating sepsis and other diseases. The study highlights the importance of gut microbiota in maintaining normal immune function and the intestinal barrier, with Clostridium butyricum playing a protective role in various conditions. The research aims to further explore the therapeutic potential of Clostridium butyricum in treating sepsis, offering new insights for clinical treatment. [Extracted from the article]

Researchers from Rochester General Hospital conducted a study analyzing outcomes and trends of allogeneic hematopoietic stem cell transplantation (HSCT) in patients with Myelodysplastic Syndromes (MDS) using data from the National Inpatient Sample (NIS) from 2016 to 2020. The study found that MDS patients undergoing HSCT were older and had a higher burden of comorbidities compared to non-MDS patients. Despite advancements in supportive care, MDS patients experienced higher in-hospital mortality and complications such as mechanical ventilation and neutropenic fever. The study also noted a steady increase in the proportion of allogeneic HSCT performed on MDS patients from 2016 to 2019, with a slight decline in 2020 possibly due to the COVID-19 pandemic. [Extracted from the article]

A study conducted at the Dana-Farber Cancer Institute in Boston, Massachusetts, focused on the utility of stool studies in pediatric hematopoietic stem cell transplant patients. The research found that bacterial and parasitic stool studies had limited diagnostic value, with low rates of positivity despite being commonly used. The researchers recommended avoiding routine use of these studies in post-transplant pediatric patients to prevent unnecessary testing costs, unless specific clinical circumstances warrant their use. [Extracted from the article]

The patent application by Marcos M. Pires introduces a live cell assay to determine the permeability of test molecules to and within the peptidoglycan scaffold of bacterial cells. This assay aims to provide a systematic analysis of surface accessibility in live bacterial cells, particularly focusing on the impact of teichoic acids on molecule permeability. The application outlines methods for assessing permeability and potential treatments for bacterial infections, emphasizing the importance of understanding molecular interactions within bacterial cells. [Extracted from the article]

Researchers at Technical University Munich (TU Munich) in Germany have discovered that Clostridium ragsdalei can produce (S)-2-hydroxyisovalerate (2-HIV) from d-xylose in various conditions. The study found that mixotrophic batch processes resulted in improved production of 2-HIV compared to autotrophic processes. This alpha-hydroxy acid has potential applications in bioplastics or composite materials. Financial support for the research came from the German Research Foundation DFG. [Extracted from the article]

Researchers from Universitas Brawijaya conducted a study on the impact of different high-fat diets on gut microbiota composition and butyrate levels in a rat model of non-alcoholic fatty liver disease (NAFLD). The study found that high-fat diets led to decreased butyrate levels and changes in gut microbiota composition, potentially influencing the development of NAFLD. The research highlights the importance of diet in altering the gut microbiome and its implications for liver health. [Extracted from the article]

A study conducted at Guangdong Ocean University in Zhanjiang, China, focused on the effects of supplementing Clostridium butyricum LV1 lyophilized powder to cottonseed protein concentrate diets on Litopenaeus vannamei. The research found that the addition of the lyophilized powder improved growth, intestinal microbiota, and immunity in the shrimp. The study concluded that an appropriate level of supplementation was 8.79 x 10(6) CFU/g. This peer-reviewed research provides valuable insights into enhancing aquaculture practices. [Extracted from the article]

A recent study conducted by the South China Sea Fisheries Research Institute in Guangzhou, China, explores the application of Clostridium butyricum in shrimp aquaculture. Clostridium butyricum, a gram-positive bacterium, has shown potential in improving growth performance, digestibility, immune response, and disease resistance in aquatic animals. The research aims to provide insights into utilizing Clostridium butyricum as an antibiotic substitute for disease prevention and treatment in shrimp aquaculture, ultimately promoting the industry's high-quality development. [Extracted from the article]

The article discusses the implementation of a genome-scale model of Clostridium luticellarii for upgrading syngas fermentations. Syngas fermentation is a method to convert waste streams into carboxylic acid precursors for biochemicals, with Clostridia species like C. luticellarii showing promise in this process. The study creates a metabolic model of C. luticellarii, highlighting its potential for acetogenesis from syngas and chain elongation, with simulations suggesting it could enhance syngas fermenting platforms. The findings emphasize the need for experimental verification and further research to advance syngas fermentation using C. luticellarii. [Extracted from the article]

A recent study conducted at Suez University in Egypt focused on the potential of Clostridium butyricum NE133 to enhance hydrogen production from anaerobic digestion of fruit and vegetable peels. The research highlighted the genetic identification of NE133 and its ability to produce hydrogen from watermelon peels, with significant improvements observed through physicochemical treatment. The findings suggest the feasibility of converting agricultural waste into renewable energy sources, emphasizing the role of C. butyricum NE133 in sustainable biohydrogen production. [Extracted from the article]

Researchers at Chongqing Medical and Pharmaceutical College in China have conducted a study on the molecular structure and biological function of the alpha toxin of Clostridium perfringens, a Gram-positive endospore-forming bacterium. The alpha toxin is a multifunctional enzyme that can cause cell lysis and various clinical effects, such as cytotoxicity and skin necrosis. The study aims to contribute to controlling disease progression, identifying therapeutic targets, and reducing the toxic effects of vaccines. For more information, readers can refer to the Canadian Journal of Veterinary Research. [Extracted from the article]

A patent application titled "Feed Additive Composition" was published online, detailing a combination of direct-fed microbials (DFM) or probiotics with enzymes to improve nutrient utilization and production performance in animals. The application emphasizes the use of DFMs as antimicrobial replacements to reduce the need for antibiotics in animal feed, highlighting the potential benefits of inhibiting pathogen growth, stimulating immune function, and modulating microbial balance in the gastrointestinal tract. The composition includes specific bacterial strains like Bacillus subtilis and various proteases, aiming to enhance animal health and performance while reducing the reliance on antibiotics in the feed industry. [Extracted from the article]

Researchers from Medical Center Leeuwarden in the Netherlands published a case report on an unusual prosthetic joint infection caused by Clostridium perfringens following total hip arthroplasty in an elderly woman. This case, the first of its kind, was successfully treated with a one-stage infection revision and twelve weeks of antibiotics. The diagnosis was confirmed through perioperative tissue and sonication cultures, highlighting the importance of accurate diagnostic methods in treating such infections. The study emphasizes the need for awareness of uncommon pathogens like C. perfringens in prosthetic joint infections and the effectiveness of specific treatment approaches. [Extracted from the article]

Researchers from Akershus University Hospital conducted a study comparing Collagenase Clostridium histolyticum (CCH) and percutaneous needle fasciotomy (PNF) as treatments for Dupuytren disease. The study involved 80 patients with primary metacarpophalangeal joint contracture and found that both methods were equally effective in reducing contracture, but CCH provided longer-lasting correction. Patients in the PNF group had higher rates of recurrence and retreatment compared to the CCH group. The study concluded that both treatments were effective, with CCH showing better long-term results. [Extracted from the article]

Researchers from the Beijing Academy of Agriculture and Forestry Sciences conducted a study on clostridium fermentation in alfalfa silage, focusing on the identification and correlation analysis of key Clostridia and LAB species. The study found that LAB inoculants like Enterococcus faecalis, Lactiplantibacillus buchneri, and Lactiplantibacillus pentosus showed significant inhibitory effects on clostridial fermentation. These findings suggest potential LAB inoculants for targeted inhibition of clostridial fermentation in alfalfa silage. The research was supported by the National Natural Science Foundation of China and the Youth Research Fund of Baafs. [Extracted from the article]

Researchers from the Swiss Federal Institute of Technology Lausanne (EPFL) have identified key enzymes, BaiJ and BaiB, in the chenodeoxycholic acid 7a-dehydroxylation pathway in the gut microbe Clostridium scindens ATCC 35704. This process is crucial for the production of secondary bile acids important for human health. The study found that a set of five enzymes, including BaiJ, can support the transformation, highlighting variations in the pathway among microorganisms and the significance of CoA ligation in the process. The findings shed light on the biochemical mechanisms involved in bile acid transformation and its potential impact on human health. [Extracted from the article]

The article from Genomics & Genetics Weekly discusses research conducted at Institut Teknologi Bandung on Escherichia coli, focusing on the cloning and optimized expression of Bst DNA polymerase from Geobacillus stearothermophillus in Escherichia coli BL21. The study aimed to construct and optimize the expression of Bst DNA polymerase for cost-effective in-house production, as commercial options are economically challenging. The research successfully achieved optimal expression of the enzyme, with a protein yield of 2,175 mg/L culture, demonstrating effective polymerase activity for Loop-Mediated Isothermal Amplification (LAMP). [Extracted from the article]

Researchers at Khon Kaen University conducted a study on biogas upgrading and acetic acid production using Clostridium thailandense supplemented with granular activated carbon (GAC) and L-arginine. The study found that adding 7.5 g/L GAC increased CH4 purity in biogas, leading to higher CO2 and H2 consumption efficiencies. The research identified hydrogenase genes and NADH-dependent ferredoxin-NADP+ oxidoreductase (Nfn) as crucial for enhancing biogas upgrading efficiency in C. thailandense. This study provides insights into optimizing sustainable biogas production through strategic GAC utilization. [Extracted from the article]

A recent study from Dartmouth College focused on Clostridium thermocellum, a bacterium with potential for cellulosic biofuel production. Researchers attempted to enhance ethanol production by expressing different alcohol dehydrogenase genes in the bacterium, but found that none of them increased ethanol production, with some even decreasing it. This study sheds light on the relationship between Clostridium thermocellum's ethanol production and the preferences of alcohol dehydrogenase enzymes. The findings provide a basis for future research on how enzyme properties impact ethanol production in this organism. [Extracted from the article]

Researchers at Shantou University in China conducted a study on the effects of dietary probiotics, specifically Clostridium butyricum I9, G15, and Paraclostridium bifermentans X13, on Pacific white shrimp. The results showed that the probiotics improved growth, immunity, and disease resistance in the shrimp, enhancing survival rates and maintaining intestinal health. This research provides valuable insights for the aquaculture industry and highlights the potential benefits of probiotic supplementation in shrimp farming. [Extracted from the article]

A recent study from the University of Pittsburgh School of Medicine explores the relationship between differentiated C2C12 muscle cells and toxin production by Clostridium perfringens type A strain ATCC3624, which causes gas gangrene. The research suggests that the presence of differentiated muscle cells enhances the production of toxins, leading to increased growth of the bacteria. The study highlights the role of specific regulatory genes and toxin genes in this process, shedding light on the pathogenesis of gas gangrene. For more information, the full article can be accessed through the journal Virulence. [Extracted from the article]

Researchers from Jazan University conducted a study on the prevalence of toxigenic Clostridium difficile in hospitalized patients in the southwestern province of Saudi Arabia. They found that 10.71% of stool samples tested positive for C. difficile using immunoassay, with 5 samples confirmed using the GeneXpert molecular assay. The study aims to improve the understanding of C. difficile burden in the healthcare system in Saudi Arabia and prevent unnecessary empiric therapy. The research was published in the Libyan Journal of Medicine and funded by Jazan University. [Extracted from the article]

A study conducted at Autonomous University in Chihuahua, Mexico, focused on the biodegradation of ibuprofen and metformin by bacteria isolated from local bodies of water. The research found that bacterial strains from the Bacillus, Paenibacillus, and Pseudomonas genera showed promising results in removing these pharmaceutical contaminants from the environment. This study highlights the potential of using indigenous bacterial strains as an alternative for treating pharmaceutical products that pose environmental risks, offering a sustainable solution to contamination issues. [Extracted from the article]

A case report from Shanghai Jiao Tong University discusses a 68-year-old male with Multiple Myeloma who developed vancomycin-induced flushing syndrome after receiving oral vancomycin for Clostridium difficile infection during chemotherapy. The patient experienced facial flushing and a rash, which resolved after discontinuing vancomycin and receiving loratadine treatment. The study suggests that oral vancomycin-induced flushing syndrome may be due to mast cell activation and histamine release, but more research is needed to confirm this hypothesis. Patients with risk factors should be monitored to prevent this rare complication. [Extracted from the article]

Researchers from Bharathidasan University in Tamil Nadu, India, have conducted a study on Clostridium botulinum, a bacterium that produces potent botulinum neurotoxin type A1. The research focused on predicting and assigning functions to the operome of C. botulinum, identifying new drug targets for treating diseases caused by this bacterium. The study revealed new metabolic and virulence proteins that enable C. botulinum to interact with the human gastrointestinal tract, offering potential avenues for developing treatments. This research provides valuable insights into the cellular and metabolic processes of C. botulinum, emphasizing the importance of understanding its adaptive strategies. [Extracted from the article]

Researchers have submitted a patent application for genetically engineered microbes designed to treat various diseases and disorders by regulating the transport of target molecules associated with the conditions. The invention aims to increase the therapeutic efficacy of the microbes by expressing a heterologous transporter linked to an inducible promoter. This innovative approach could potentially address a wide range of health issues, including immune diseases, autism, cancer, metabolic disorders, obesity, and infections, among others. The patent application outlines the method of producing a pharmaceutically acceptable composition using these genetically engineered non-pathogenic bacteria for therapeutic purposes. [Extracted from the article]

Researchers from the State University of New York (SUNY) Buffalo have conducted studies on Clostridium perfringens, a Gram-Positive Endospore-Forming Bacteria that causes gastrointestinal disorders. The research focuses on how the Clostridium perfringens enterotoxin binds to receptors called claudins on the small intestinal epithelium, leading to gut cytotoxicity. The study proposes a model of claudin/CpE assembly and strategies to obstruct its formation to treat diseases caused by Clostridium perfringens. For more information, readers can refer to the article "Cryo-em Structures of Clostridium Perfringens Enterotoxin Bound To Its Human Receptor, Claudin-4" published in Structure. [Extracted from the article]

Researchers at the State University of New York (SUNY) Buffalo have published findings on Clostridium perfringens, a Gram-Positive Endospore-Forming Bacteria that causes gastrointestinal disorders. The study focuses on how Clostridium perfringens enterotoxin binds to receptors called claudins on the small intestinal epithelium, leading to gut cytotoxicity. The research proposes a model of claudin/CpE assembly and strategies to obstruct its formation for treating Clostridium perfringens enterotoxin-related diseases. The study was supported by various organizations including the NIH and NSF, and the findings were published in the journal Structure. [Extracted from the article]

Researchers at Philipps-University in Marburg, Germany, have found that metabolites derived from the human commensal Clostridium sporogenes can protect mice against colonic inflammation. The metabolites include indole-3-propionic acid, branched-chain acids, and short-chain fatty acids. This study suggests that C. sporogenes could be a potential probiotic for patients with inflammatory bowel disease. The research was funded by various organizations and published in Gut Microbes. [Extracted from the article]